Citation Impact
Citing Papers
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
2008
Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance
2003
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
TGF-β and cancer
1999
Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor
1999
Myeloid-derived suppressor cells coming of age
2018 Standout
The Expression of Proto‐Oncogene eIF4E in Laryngeal Squamous Cell Carcinoma
2003
Lymphangiogenesis and cancer metastasis
2002 Standout
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
2001
Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis
2001
The tor pathway: a target for cancer therapy
2004 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
2002 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism
2000
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Multi-protein assemblies underlie the mesoscale organization of the plasma membrane
2014 StandoutNobel
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
INDUCTION OF PROINFLAMMATORY AND CHEMOKINE GENES BY LIPOPOLYSACCHARIDE AND PACLITAXEL (Taxol™) IN MURINE AND HUMAN BREAST CANCER CELL LINES
2001
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Colony-stimulating factors in inflammation and autoimmunity
2008
Tissue-resident macrophages
2013 Standout
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus
2020
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
2017
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
1999
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers
1999
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D 3
2004
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma
1999
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
2011 StandoutNobel
Inflammation and cancer: back to Virchow?
2001 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
2015 StandoutNobel
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Paradoxical roles of the immune system during cancer development
2006 Standout
Microenvironmental regulation of metastasis
2008 Standout
Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cells
2001
Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid Cells
2006
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
2012
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
The Effect of Tetrathiomolybdate on Cytokine Expression, Angiogenesis, and Tumor Growth in Squamous Cell Carcinoma of the Head and Neck
2005
Immature myeloid cells and cancer-associated immune suppression
2002
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
2011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Comparison of Serum Interleukin-10 (IL-10) Levels Between Normal Volunteers and Patients with Advanced Melanoma
2001
Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
2008
Derangement of immune responses by myeloid suppressor cells
2003
High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells
2004
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
2000
Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
1999
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
2010
Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro
2005
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
2005
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
2001
Cooperative Autocrine and Paracrine Functions of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in the Progression of Skin Carcinoma Cells
2004
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
2008
CD34+ Immune Suppressive Cells in the Peripheral Blood of Patients with Head and Neck Cancer
2000
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
2007
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion
2008
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
2000
Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma
1999
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
2005
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
2002
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
2003
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
2006
Fatty acids, the immune response, and autoimmunity: A question of n−6 essentiality and the balance between n−6 and n−3
2003
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells
1998
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
1999
Increased Levels of Immune Inhibitory Cd34+ Progenitor Cells in the Peripheral Blood of Patients with Node Positive Headc and Neck Squamous Cell Carcinomas and The Ability of These CD34+ Cells to Differentiate Into Immune Stimulatory Dendritic Cells
2001
Works of Janet Benefield being referenced
Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells
1997
Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
1996
Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells
1997
Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells
1997
Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation
1997
Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
1996
Endothelial cell response to human head and neck squamous cell carcinomas involves downregulation of protein phosphatases-1/2A, cytoskeletal depolymerization and increased motility.
1997
Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte‐macrophage colony‐stimulating factor and contained CD34 natural suppressor cells
1997